Chester S. Zygmont III - 29 Oct 2025 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Financial Officer
Signature
/s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont III
Issuer symbol
REVB
Transactions as of
29 Oct 2025
Transactions value $
$499,986
Form type
4
Filing time
31 Oct 2025, 12:55:28 UTC
Previous filing
13 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zygmont Chester Stanley III Chief Financial Officer C/O REVELATION BIOSCIENCES, INC., 4660 LA JOLLA VILLAGE DR., SUITE 100, SAN DIEGO /s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont III 31 Oct 2025 0001900657

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $500K +391K +7764.14% $1.28 396K 29 Oct 2025 By Trust F1, F2
holding REVB Common Stock 5.03K 29 Oct 2025 By Trust F2
holding REVB Common Stock 5 29 Oct 2025 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the date of grant.
F2 Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
F3 Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.